Dr. Gerald Post

The Veterinary Cancer Center Joins Compassion-First Pet Hospitals

NORWALK, CT – July 20, 2016 –The Veterinary Cancer Center (The VCC) of Norwalk, Connecticut, announced today, it is merged with the Compassion-First Pet Hospitals family of well-known veterinary hospitals.

Located at 129 Glover Ave, in Norwalk, The VCC was founded in 1998 by Gerald Post, DVM, MEM, DACVIM (Oncology) and is the only specialized veterinary practice dedicated to the diagnosis and treatment of cancer in animals.

Pet Meds Adapted from Human Therapies

Dr. Post is one of the co-founder of a company called Innogenics which provides a genomic test of canine cancer, ordered after standard histopathology; that probes the expression levels of nearly three dozen cancer-related genes. They were just featured in The Scientist and is a fascinating article about Companies focused on developing treatments for dogs, cats and horses are bringing a diverse array of products to the pet medicine market - story by By Jenny Rood | October 1, 2016

Blue Buffalo and Dr. Gerald Post partner for Pet Cancer Awareness Month

As people in the pet world are most likely aware of, May is Pet Cancer Awareness Month. In light of that Blue Buffalo® has partnered with Dr. Gerald Post, a top-rated veterinary oncologist in order to raise awareness about possible causes, signs and prevention tips to help save more beloved cats and dogs.

Medical Oncologist Wanted

The Veterinary Cancer Center (VCC) (www.vcchope.com) is seeking a board-certified or residency trained medical oncologist for a Long Island Comprehensive Cancer Center as well as at location in East End Veterinary Center, NY, Red Bank Veterinary Hospital: Hillsborough, NJ, Red Bank Veterinary Hospital: Mount Laurel, NJ, VRC, PA.

Dr. Post's on Animal Radio

Innogenics —Genomic Profiling for Pets: What information can it provide

Innogenics is a specialty genomics reference laboratory that helps veterinarians and owners of pets with cancer by providing state-of-the-art molecular diagnostic analysis of tumor tissue at costs affordable to the pet owner. We provide a molecular profile of a dog’s tumor that details the cancer type and subtype and provides biomarker information useful in guiding decisions about current and novel therapeutic options. 

The Future of Veterinary Medicine - Here Today!

Dear Friends and Colleagues,

Personalized Medicine for Pets

These days, if you read any news article about human health, the words “personalized medicine” likely appear somewhere in the story.

What is personalized medicine? Is it really that revolutionary? How can personalized medicine be useful to veterinary medicine?

The 9th Annual Veterinary Cancer Center Continuing Education Lecture

Guide to Canine Cancer: Your Most Common Questions Answered

This article is brought to you by DogChannell.com - DOG FANCY, Dog WorldDogs in ReviewDogs for KidsPopular DogsPopular PuppiesDogs USAPuppies USA, and DogChannel.com are part of the I-5 Publishing LLC stable of magazines and books. I-5 Publishing LLC is the leader in special interest pet magazines, trade magazines, books, and websites dedicated to pet-loving consumers, pet-supply retailers, veterinarians, breeders and pet professionals worldwide.